Literature DB >> 12654804

Oral transfer of adult Ancylostoma ceylanicum hookworms into permissive and nonpermissive host species.

Richard D Bungiro1, Brett R Anderson, Michael Cappello.   

Abstract

Syrian hamsters become anemic and exhibit delayed growth following oral infection with third-stage Ancylostoma ceylanicum hookworm larvae. Here we describe experiments designed to determine the feasibility of adult worm transfer (AWT) between hosts, a technique that would facilitate the specific study of bloodfeeding hookworms in vivo without prior exposure of the host to larva-specific antigens, permit the ex vivo manipulation of adult parasites prior to reimplantation, and also allow for cross-species transfer of worms. Weanling hamsters given an oral AWT of 40 or 60 mixed-sex A. ceylanicum worms rapidly developed anemia; in the higher-dose group, hemoglobin levels declined from prechallenge levels by 44% within 4 days following AWT. Long-term survival of transferred worms was demonstrated by recovery of parasites from the intestines 42 days after AWT. AWT hamsters acquired humoral immune responses against soluble adult hookworm extracts and excretory-secretory products that were comparable in magnitude to those of animals given a typical infection with larvae. In AWT experiments employing the nonpermissive murine model, C57BL/6 mice given adult worms rapidly became anemic and lost weight in a manner similar to AWT hamsters. Infection of additional mouse strains demonstrated that while C57BL/10 and CD-1 mice also developed anemia following AWT, BALB/c mice were resistant. The technique of AWT to mice may further our understanding of hookworm pathogenesis by allowing the study of adult hookworm infections in a species with well-characterized genetics and an abundance of available reagents.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12654804      PMCID: PMC152085          DOI: 10.1128/IAI.71.4.1880-1886.2003

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  The hookworm platelet inhibitor: functional blockade of integrins GPIIb/IIIa (alphaIIbbeta3) and GPIa/IIa (alpha2beta1) inhibits platelet aggregation and adhesion in vitro.

Authors:  R C Chadderdon; M Cappello
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

2.  Ancylostoma ceylanicum excretory/secretory protein 1: purification and molecular cloning of a major secretory protein from adult hookworms.

Authors:  Richard D Bungiro; Lisa M Harrison; Michael Cappello
Journal:  Mol Biochem Parasitol       Date:  2002-01       Impact factor: 1.759

3.  Migration and growth of Ancylostoma ceylanicum in golden hamsters Mesocricetus auratus.

Authors:  D K Ray; K K Bhopale; V B Shrivastava
Journal:  J Helminthol       Date:  1972       Impact factor: 2.170

4.  The infectivity of ingested adult hookworms.

Authors:  D K Ray; V B Shrivastava
Journal:  Trans R Soc Trop Med Hyg       Date:  1981       Impact factor: 2.184

5.  Effects of host endocrine gland removal on the permissive status of laboratory rodents to infection by Schistosoma mansoni.

Authors:  P M Knopf; M Soliman
Journal:  Int J Parasitol       Date:  1980-06       Impact factor: 3.981

Review 6.  Immune responses in hookworm infections.

Authors:  A Loukas; P Prociv
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

7.  Cleavage of hemoglobin by hookworm cathepsin D aspartic proteases and its potential contribution to host specificity.

Authors:  Angela L Williamson; Paul J Brindley; Giovanni Abbenante; Paul Prociv; Colin Berry; Karen Girdwood; David I Pritchard; David P Fairlie; Peter J Hotez; John P Dalton; Alex Loukas
Journal:  FASEB J       Date:  2002-07-18       Impact factor: 5.191

Review 8.  Nutritional impact of intestinal helminthiasis during the human life cycle.

Authors:  D W T Crompton; M C Nesheim
Journal:  Annu Rev Nutr       Date:  2002-01-04       Impact factor: 11.848

9.  Development of Ancylostoma ceylanicum Looss, 1911 (hamster strain) in the albino mouse, Mus musculus, with and without cortisone.

Authors:  D K Ray; K K Bhopale; V B Shrivastava
Journal:  Parasitology       Date:  1975-10       Impact factor: 3.234

10.  Complete development of ancylostoma ceylanicum (Looss, 1911) in golden hamsters, mesocricetus auratus.

Authors:  D K Ray; K K Bhopale
Journal:  Experientia       Date:  1972-03-15
View more
  6 in total

1.  Molecular characterization of Ancylostoma ceylanicum Kunitz-type serine protease inhibitor: evidence for a role in hookworm-associated growth delay.

Authors:  Daniel Chu; Richard D Bungiro; Maureen Ibanez; Lisa M Harrison; Eva Campodonico; Brian F Jones; Juliusz Mieszczanek; Petr Kuzmic; Michael Cappello
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

2.  Dietary iron content mediates hookworm pathogenesis in vivo.

Authors:  Melissa R Held; Richard D Bungiro; Lisa M Harrison; Iqbal Hamza; Michael Cappello
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

3.  Frequency and intensity of exposure mediate resistance to experimental infection with the hookworm, Ancylostoma ceylanicum.

Authors:  Dylan Davey; Nisha Manickam; Benjamin T Simms; Lisa M Harrison; Jon J Vermeire; Michael Cappello
Journal:  Exp Parasitol       Date:  2012-12-08       Impact factor: 2.011

4.  Purification and molecular cloning of and immunization with Ancylostoma ceylanicum excretory-secretory protein 2, an immunoreactive protein produced by adult hookworms.

Authors:  Richard D Bungiro; Carolina V Solis; Lisa M Harrison; Michael Cappello
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

Review 5.  Of dogs and hookworms: man's best friend and his parasites as a model for translational biomedical research.

Authors:  Catherine Shepherd; Phurpa Wangchuk; Alex Loukas
Journal:  Parasit Vectors       Date:  2018-01-25       Impact factor: 3.876

Review 6.  Immunity to Soil-Transmitted Helminths: Evidence From the Field and Laboratory Models.

Authors:  Stefano A P Colombo; Richard K Grencis
Journal:  Front Immunol       Date:  2020-06-23       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.